BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
See all
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
See all
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
Monoclonal Antibody Productivity
Single Use
A Fully Single-Use Downstream Process for Monoclonal Antibodies
A Fully Single-Use Downstream Process for Monoclonal Antibodies
by
Shunsuke Shiina,
Neha Saxena
and 1 more
Apr 17, 2024
Artificial intelligence
Information Technology
Using Artificial Intelligence for Monoclonal Antibody Discovery
Using Artificial Intelligence for Monoclonal Antibody Discovery
by
William Whitford
Apr 17, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
See all
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
See all
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX
Emerging Therapeutics
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
by
Suranjana Sen
Apr 17, 2024
Characterization methodologies
Emerging Therapeutics
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
by
Sanjib Banerjee,
Rajiv Bharadwaj
Apr 17, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Deal Making
Alvotech to manufacture Humira biosimilar for Quallent
Alvotech to manufacture Humira biosimilar for Quallent
by
Millie Nelson
May 3, 2024
1 Min Read
thumbnail
Therapeutic Class
Oxford Biomedica eyes global market amid hawkish trends
Oxford Biomedica eyes global market amid hawkish trends
by
Shreeyashi Ojha
May 2, 2024
2 Min Read
Home
White Papers
Featured on White Papers
Build vs. Buy: A Critical Calculation for Cell Therapy Innovators
Sponsored Content
Build vs. Buy: A Critical Calculation for Cell Therapy Innovators
Build vs. Buy: A Critical Calculation for Cell Therapy Innovators
by
BPI Contributor
Dec 2, 2021
|
1 Min Read
Five Ways the Amersham ImageQuant™ 800 GxP Helps You Remain Compliant
Sponsored Content
Five Ways the Amersham ImageQuant™ 800 GxP Helps You Remain Compliant
Five Ways the Amersham ImageQuant™ 800 GxP Helps You Remain Compliant
by
BPI Contributor
Nov 24, 2021
1 Min Read
3M™ Polisher ST — The Next Frontier in Downstream Processing, a Frost & Sullivan White Paper
Sponsored Content
3M™ Polisher ST — The Next Frontier in Downstream Processing, a Frost & Sullivan White Paper
3M™ Polisher ST — The Next Frontier in Downstream Processing, a Frost & Sullivan White Paper
by
BPI Contributor
Nov 17, 2021
2 Min Read
Scale-Down Optimization to Scale Up Success
Sponsored Content
Scale-Down Optimization to Scale Up Success
Scale-Down Optimization to Scale Up Success
by
BPI Contributor
Nov 16, 2021
1 Min Read
MAb Quantitation: Protein A HPLC vs. Protein A Bio-Layer Interferometry
Sponsored Content
MAb Quantitation: Protein A HPLC vs. Protein A Bio-Layer Interferometry
MAb Quantitation: Protein A HPLC vs. Protein A Bio-Layer Interferometry
by
BPI Contributor
Nov 10, 2021
1 Min Read
Why Choose Eurofins BioPharma Product Testing?
Sponsored Content
Why Choose Eurofins BioPharma Product Testing?
Why Choose Eurofins BioPharma Product Testing?
by
BPI Contributor
Nov 8, 2021
1 Min Read
More from White Papers
Sponsored Content
The Viscosity Reduction Platform: Viscosity-Reducing Excipients for Protein Formulation
The Viscosity Reduction Platform: Viscosity-Reducing Excipients for Protein Formulation
Nov 8, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Accelerating Discoveries for Viral Biology and Host Immunity with Advanced Cell Analysis Solutions
Accelerating Discoveries for Viral Biology and Host Immunity with Advanced Cell Analysis Solutions
Nov 2, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Using Bio-Layer Interferometry for A Fast and High Precision Influenza Vaccine Potency Assay
Using Bio-Layer Interferometry for A Fast and High Precision Influenza Vaccine Potency Assay
Oct 25, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Assessing Your AAV Capsid Content for Product Quality? Get the Confidence You Need with an Automated CE Platform
Assessing Your AAV Capsid Content for Product Quality? Get the Confidence You Need with an Automated CE Platform
Oct 25, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Cell Line Development: Accelerating Process Optimization by Combining Ambr® 15 Cell Culture with Octet® Titer Measurements
Cell Line Development: Accelerating Process Optimization by Combining Ambr® 15 Cell Culture with Octet® Titer Measurements
Oct 21, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Enhancement of Tablet Coating Using an Innovative Functional Excipient
Enhancement of Tablet Coating Using an Innovative Functional Excipient
Oct 20, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Cytiva Strategy for Host Cell Protein Control
Cytiva Strategy for Host Cell Protein Control
Oct 20, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
CAP®Ad – A Versatile Platform for RCA-free, Industrial Scale Adenoviral Vector Production
CAP®Ad – A Versatile Platform for RCA-free, Industrial Scale Adenoviral Vector Production
Oct 14, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
The Importance of Raw Materials in Viral Vector Manufacturing
The Importance of Raw Materials in Viral Vector Manufacturing
Oct 13, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
Oct 12, 2021
|
1 Min Read
by
BPI Contributor
Sponsored Content
A Guide to Accelerating Cell Line Development for Commercial Production
A Guide to Accelerating Cell Line Development for Commercial Production
Oct 12, 2021
|
1 Min Read
by
BPI Contributor